Dr. Rachel L. Moore Featured in Bariatric Times
October 7, 2019
Page Updated:
Qsymia® is intended for adults with a BMI of 30 or more and should be used in conjunction with a reduced-calorie diet and increased physical activity for chronic weight management.
Qsymia® is the only FDA-approved once daily weight loss medication. Qsymia® contains two weight loss medications – PHENTERMINE starts working immediately and is thought to reduce your appetite while TOPIRAMATE works throughout the day to help you feel full.
If Qsymia® turns out to be a right fit for you, Dr. Moore will prescribe this medication in combination with a reduced-calorie diet and increased physical activity.
In a clinical trial, adults who took the recommended dose of Qsymia® and completed the study achieved an average weight loss of 22 pounds (nearly 10% of their excess body weight) and average reduction in waist circumference of 4 inches. *Results may vary
The all-important first step in your weight loss journey is to schedule a consultation with Dr. Moore or Dr. Thomas to assess if you are an ideal candidate for Qsymia®.
Contact us today to schedule your appointment.
The Doctors at Moore Metabolics have either authored or reviewed and approved this content.